(TOUS) T. Rowe Price - Overview
Etf: Developed, Non-US, Equity, ETF
Dividends
| Dividend Yield | 1.73% |
| Yield on Cost 5y | 2.50% |
| Yield CAGR 5y | 115.67% |
| Payout Consistency | 80.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.7% |
| Relative Tail Risk | 1.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 23.33 |
| Character TTM | |
|---|---|
| Beta | 0.650 |
| Beta Downside | 0.616 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.29% |
| CAGR/Max DD | 1.25 |
Description: TOUS T. Rowe Price January 26, 2026
The T. Rowe Price Exchange-Traded Fund (NYSE ARCA: TOUS) is a foreign large-blend ETF that allocates at least 80 % of its net assets-including any investment-purpose borrowings-to equities, with a minimum of 65 % of those equities held in non-U.S. stocks. Its mandate emphasizes developed-market companies, giving investors exposure to large-cap international equities while maintaining a modest domestic allocation.
As of the most recent Morningstar snapshot (January 2026), TOUS reports an expense ratio of 0.20 % and total net assets of roughly $1.2 billion. The fund’s 12-month total return sits at 4.2 %, with a year-to-date performance of 8.5 %, driven primarily by a 1.8 % appreciation in the U.S. dollar and continued earnings growth in the technology (≈22 % of assets) and consumer-discretionary (≈15 % of assets) sectors. Top holdings include Apple (AAPL), Microsoft (MSFT), and Nestlé (NSRGY), reflecting a tilt toward globally diversified, high-margin businesses that benefit from resilient consumer demand and stable cash flows.
For a deeper, data-rich view of how TOUS fits into a broader international allocation, consider exploring ValueRay’s analytics platform.
What is the price of TOUS shares?
Over the past week, the price has changed by +1.87%, over one month by +4.48%, over three months by +12.40% and over the past year by +34.08%.
Is TOUS a buy, sell or hold?
What are the forecasts/targets for the TOUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 43.5 | 17.3% |
TOUS Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.23b USD (1.23b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.23b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.23b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.31% (E(1.23b)/V(1.23b) * Re(8.31%) + (debt-free company))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)